Cencora 

$219.94
241
-$1.02-0.46% Friday 20:00

统计数据

当日最高
221.15
当日最低
219.35
52周最高
247.66
52周最低
182.62
成交量
1,581,839
平均成交量
1,435,339
市值
46.96B
市盈率
25.98
股息收益率
0.93%
股息
2.04

即将到来

股息

0.93%股息收益率
10年增长
7.44%
5年增长
4.98%
3年增长
4.65%
1年增长
3.82%

收益

6Nov预期
Q2 2022
Q3 2022
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
2.57
2.98
3.39
3.8
预期每股收益
3.2
实际每股收益
N/A

人们还关注

此列表基于关注COR的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

分析师评级

269.83$平均价格目标
最高估值为 $287。
来自过去6个月内的 6 个评级。这不是投资建议。
买入
67%
持有
33%
卖出
0%

关于

Finance
Real Estate Investment Trusts
Finance and Insurance
Other Financial Vehicles
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Show more...
首席执行官
Steven Collis
员工
46000
国家
US
ISIN
US03073E1055

上市公司